Description

Product Description

Etoposide is a well-known semisynthetic epipodophyllotoxin derivative designed to inhibit DNA topoisomerase II, a crucial enzyme responsible for managing DNA topology during replication and transcription. The inhibition of this enzyme results in DNA double-strand breaks and subsequent activation of apoptotic signaling pathways. Because of its specific mechanism of action and broad research relevance, Etoposide remains a cornerstone compound in molecular oncology and pharmacology.

Etoposide was first derived from podophyllotoxin, a natural lignan extracted from Podophyllum peltatum (mayapple plant). Its molecular structure incorporates glycosidic and aromatic moieties that facilitate interactions with DNA-enzyme complexes. Researchers have long relied on Etoposide as a benchmark molecule for modeling cytotoxicity, genotoxicity, and chemotherapeutic response.

In laboratory settings, Etoposide is commonly applied to study the induction of DNA strand scission, p53 activation, and checkpoint signaling in eukaryotic cells. Its activity spectrum spans from cell culture models to in vivo systems, where it demonstrates dose-dependent modulation of apoptosis, cell cycle arrest (primarily at the G2/M phase), and enhancement of DNA repair pathways.

Molecular and Mechanistic Insights

Etoposide operates by stabilizing the transient DNA-topoisomerase II cleavable complex. Under normal conditions, topoisomerase II introduces reversible double-stranded breaks to relieve torsional stress in DNA. However, Etoposide “freezes” this intermediate complex, preventing the religation of DNA strands. This stabilization converts a transient enzymatic step into a lethal lesion, which triggers intrinsic apoptotic cascades.

The drug’s selectivity toward rapidly proliferating cells makes it valuable in research exploring tumor kinetics and DNA replication stress. It also serves as a molecular probe in understanding DNA damage repair via non-homologous end joining (NHEJ) and homologous recombination (HR) mechanisms.

Researchers have also utilized Etoposide to induce genotoxic stress in controlled models, thereby enabling the assessment of checkpoint kinases (CHK1, CHK2) and tumor suppressors (p53, BRCA1, ATM, and ATR). Its effects are dose- and time-dependent, providing flexible parameters for experimental design.

Applications in Research

Etoposide is frequently employed across multiple domains of biomedical research:

• Cancer Biology: Investigation of cytotoxic mechanisms, apoptosis induction, and DNA repair modulation.

• Molecular Pharmacology: Testing the synergy of DNA-damaging agents with targeted kinase inhibitors.

• Genotoxicity Studies: Evaluating mutagenic potential and oxidative stress markers.

• Cell Cycle Research: Analyzing checkpoint arrest and recovery mechanisms.

• Drug Resistance Modeling: Studying multidrug resistance transporters (e.g., P-glycoprotein).

The compound’s extensive characterization makes it a reference tool in comparative analyses of topoisomerase-targeting agents such as doxorubicin, teniposide, and amsacrine.

Product Specifications

Mechanism of Action

Etoposide inhibits DNA topoisomerase II by forming a ternary complex with the enzyme and DNA substrate. This interaction prevents the resealing of transient DNA double-strand breaks, leading to accumulation of irreparable DNA damage and subsequent cell death.

Upon Etoposide exposure, cells undergo a cascade of molecular events. The persistent DNA breaks activate the ATM/ATR kinases, leading to phosphorylation of downstream effectors such as CHK2 and p53. This results in transcriptional upregulation of p21 and Bax, promoting cell cycle arrest and mitochondrial apoptosis.

The drug’s cytotoxicity is influenced by both cell cycle phase and cellular redox state. It predominantly affects cells in late S and G2 phases. Moreover, reactive oxygen species (ROS) generated during Etoposide metabolism further amplify DNA damage.

Interestingly, Etoposide also serves as a valuable research compound in the exploration of topoisomerase mutations and drug resistance. Overexpression of efflux pumps or mutations in topoisomerase II genes can lead to reduced sensitivity, allowing scientists to dissect adaptive mechanisms in cancer cells.

Mitochondrial and Epigenetic Pathways

Emerging research reveals that Etoposide triggers mitochondrial outer membrane permeabilization (MOMP) via the activation of pro-apoptotic Bcl-2 family members such as Bax and Bak. This initiates cytochrome c release and caspase cascade activation. Additionally, it influences epigenetic regulation by altering histone acetylation and DNA methylation patterns, contributing to gene expression remodeling under genotoxic stress.

Side Effects

Etoposide exhibits several concentration-dependent biological effects that are valuable for understanding cytotoxicity in laboratory systems.

Cellular and Molecular Toxicology

At lower concentrations, Etoposide primarily induces cell cycle arrest, while at higher concentrations, it causes extensive DNA fragmentation and apoptosis. Researchers studying cell line models such as HeLa, MCF-7, and HepG2 often utilize Etoposide to calibrate DNA damage assays or to evaluate mitochondrial dysfunction markers.

Etoposide exposure may result in elevated ROS levels, depletion of glutathione, and activation of stress kinases such as JNK and p38 MAPK. Chronic exposure conditions are associated with chromosomal aberrations and secondary mutations — critical endpoints for long-term genotoxicity evaluations.

Experimental Safety Considerations

In vitro handling of Etoposide requires adherence to chemical safety standards. The compound should be dissolved under sterile conditions and stored at low temperatures to prevent degradation. Protective equipment such as gloves, lab coats, and safety goggles is recommended during experimental use.

Keywords

Etoposide, CAS 33419-42-0, topoisomerase II inhibitor, DNA damage, apoptosis, cancer research, chemoresistance model, cell cycle arrest, genotoxicity, oncology compound, molecular pharmacology, high purity peptide supplier, China peptide manufacturer, OEM peptide production.

Shipping Guarantee

All shipments are handled using validated cold-chain logistics to preserve compound integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

This product is intended for laboratory research use only. It is not approved for human or veterinary use, nor for diagnostic or therapeutic applications. Researchers must follow institutional safety and ethical guidelines when handling or disposing of this compound.